Log in

Relevant bibliographies by topics / Diabète de type 1 – chirurgie / Journal articles

Journal articles on the topic 'Diabète de type 1 – chirurgie'

To see the other types of publications on this topic, follow the link: Diabète de type 1 – chirurgie.

Author: Grafiati

Published: 7 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Diabète de type 1 – chirurgie.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Scheen, A. J., J. De Flines, A. De Roover, and N. Paquot. "De la chirurgie bariatrique à la chirurgie métabolique : vers un nouveau paradigme dans le traitement du diabète de type 2." Médecine des Maladies Métaboliques 5, no. 3 (June 2011): 279–86. http://dx.doi.org/10.1016/s1957-2557(11)70240-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pichlerová, Dita. "The role of bariatric surgery in patients with type 1 diabetes mellitus." Gastroenterologie a hepatologie 75, no. 6 (December 31, 2021): 524–28. http://dx.doi.org/10.48095/ccgh2021524.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Bariatric surgery procedures are recognized as the most successful method of treating diabetes in obese patients with type 2 diabetes mellitus. Despite the fact that the number of obese type 1 diabetics has been constantly increasing in the last decade, bariatric surgery in these patients is still waiting to be widely used and standardized. Bariatric surgery has been proposed as an effective treatment for these patients, although data are scarce, based on case reports and retrospective studies. The article summarizes the current knowledge about the use of bariatric surgery in type 1 diabetics with obesity an cites some of the previous studies. Bariatric surgery is not yet routinely recommended in patients with type 1 diabetes mellitus.

3

Franck, M., J. de Flines, N. Paquot, A. De Roover, and A. Scheen. "P2146 Chirurgie bariatrique chez le patient diabétique de type 1 : résultats d’une expérience limitée." Diabetes & Metabolism 39 (March 2013): A102. http://dx.doi.org/10.1016/s1262-3636(13)72056-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Eas, F., G. Prévost, B. Cauliez, A. Laquerrière, P. Fréger, and J. Marc Kuhn. "029 Comparaison de l’efficacité de la chirurgie bariatrique dans le diabète de type 2 en fonction de la technique d’intervention. Analyse rétrospective chez 74 patients diabétiques opérés." Diabetes & Metabolism 37, no. 1 (March 2011): A8. http://dx.doi.org/10.1016/s1262-3636(11)70517-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Amouyal, C., and F. Andreelli. "Chirurgie métabolique du diabète de type 2." Médecine des Maladies Métaboliques 9, no. 5 (July 2015): 473–81. http://dx.doi.org/10.1016/s1957-2557(15)30200-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jaffiol, Claude, and Patrick Ritz. "Chirurgie métabolique et diabète de type 2." Bulletin de l'Académie Nationale de Médecine 196, no. 7 (October 2012): 1473–75. http://dx.doi.org/10.1016/s0001-4079(19)31729-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Mrugala, Viktoria, and Albert J. Augustin. "Das frühe Diabetische Makulaödem: Ein Indikator für schlechte postoperative Ergebnisse nach Katarakt Chirurgie bei Diabetikern. Die DICAT-II-Studie." Kompass Ophthalmologie 7, no. 4 (2021): 184–86. http://dx.doi.org/10.1159/000520147.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

<b>Background:</b> The prospective DIabetes and CATaract Study II (DICAT II) was performed to characterise the risks of cataract surgery to the retinae of patients with early diabetic macular oedema (E-DMO). <b>Methods:</b> DICAT II was a prospective, comparative, multicentre, observational study involving six Italian clinics. Patients were aged ≥55 years, had type 1 or 2 diabetes with spectral-domain optical coherence tomography evidence of ESASO classification Early DMO. Group 1 eyes (78 eyes, 78 patients) underwent phacoemulsification-based cataract surgery. Group 2 eyes (65 eyes, 65 patients) had E-DMO and either clear media or had undergone uncomplicated cataract surgery ≥1 year previously. Central subfield thickness (CST) and best-corrected visual acuity (BCVA) were assessed in both groups. <b>Results:</b> The negative impact of surgery on CST was evident after the first postoperative week; CST peaked during the first month, then rapidly decreased. CST worsening ≥10 µm was observed in 63/78 eyes (80.7%) and 29/65 eyes (44.6%) in Groups 1 and 2, respectively (<i>p</i> < 0.0001). CST worsening of ≥50 µm was observed in 51 eyes (65.4%) and 10 eyes (15.4%) in Groups 1 and 2, respectively (<i>p</i> < 0.0001). Mean CST worsening was lower in Group 2 than in Group 1 (38.6 ± 30.4 µm vs 85.5 ± 55.3 µm, <i>p</i> < 0.0001) with a lower BCVA loss (−2.6 ± 3.5 letters vs −8.2 ± 6.2 letters, <i>p</i> < 0.0001). Higher glycaemic levels and HBA1c levels were significantly associated with the risk of >50 μm CST worsening in eyes from both groups. <b>Conclusion:</b> Early DMO is associated with poorer outcomes after cataract surgery and requires close pre- and postoperative monitoring.

8

D, Y. M. "Chirurgie bariatrique : un traitement du diabète de type 2." Option/Bio 25, no. 518 (December 2014): 10. http://dx.doi.org/10.1016/s0992-5945(14)72015-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jean-Marie, Manus. "Chirurgie bariatrique, un traitement du diabète de type 2." Revue Francophone des Laboratoires 2024, no. 563 (2024): 13. http://dx.doi.org/10.1016/s1773-035x(24)76112-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Santucci, Nicolas, Sébastien Gaujoux, Christine Binquet, Cynthia Reichling, Jean-Christophe Lifante, Bruno Carnaille, François Pattou, et al. "Pancreatoduodenectomy for Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: An AFCE (Association Francophone de Chirurgie Endocrinienne) and GTE (Groupe d’étude des Tumeurs Endocrines) Study." World Journal of Surgery 45, no. 6 (March 1, 2021): 1794–802. http://dx.doi.org/10.1007/s00268-021-06005-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Abstract:

Abstract Aim To assess postoperative complications and control of hormone secretions following pancreatoduodenectomy (PD) performed on multiple endocrine neoplasia type 1 (MEN1) patients with duodenopancreatic neuroendocrine tumors (DP-NETs). Background The use of PD to treat MEN1 remains controversial, and evaluating the right place of PD in MEN1 disease makes sense. Methods Thirty-one MEN1 patients from the Groupe d’étude des Tumeurs Endocrines MEN1 cohort who underwent PD for DP-NETs between 1971 and 2013 were included. Early and late postoperative complications, secretory control and overall survival were analyzed. Results Indication for surgery was: Zollinger–Ellison syndrome (n = 18; 58%), nonfunctioning tumor (n = 9; 29%), insulinoma (n = 2; 7%), VIPoma (n = 1; 3%) and glucagonoma (n = 1; 3%). Mean follow-up was 141 months (range 0–433). Pancreatic fistulas occurred in 5 patients (16.1%), distant metastases in 6 (mean onset of 43 months; range 13–110 months), postoperative diabetes mellitus in 7 (22%), and pancreatic exocrine insufficiency in 6 (19%). Five-year overall survival was 93.3% [CI 75.8–98.3] and ten-year overall survival was 89.1% [CI 69.6–96.4]. After a mean follow-up of 151 months (range 0–433), the biochemical cure rate for MEN-1 related gastrinomas was 61%. Conclusion In MEN1 patients, pancreatoduodenectomy can be used to control hormone secretions (gastrin, glucagon, VIP) and to remove large NETs. PD was found to control gastrin secretions in about 60% of cases.

11

F.A. "Diabète: Glucagon et diabète de type 1." Médecine des Maladies Métaboliques 8, no. 3 (June 2014): 328. http://dx.doi.org/10.1016/s1957-2557(14)70813-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

D, Y. M. "La chirurgie bariatrique pour guérir le diabète de type 2." Option/Bio 26, no. 533 (November 2015): 11. http://dx.doi.org/10.1016/s0992-5945(15)30319-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

M, J. M. "La chirurgie de l’obésité neutralise le diabète de type 2." Revue Francophone des Laboratoires 2009, no. 417 (December 2009): 12. http://dx.doi.org/10.1016/s1773-035x(09)70289-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Khiari, M., S. Zribi, H. Zahra, F. Boukhayatia, R. Mizouri, A. Temessek, and F. Ben Mami. "Les complications dégénératives: diabète type 1 vs diabète de type 2." Annales d'Endocrinologie 79, no. 4 (September 2018): 494. http://dx.doi.org/10.1016/j.ando.2018.06.993.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

A, F. "Chirurgie bariatrique et diabète de type 2 : effets permanents ou temporaires ?" Médecine des Maladies Métaboliques 10, no. 6 (October 2016): 581. http://dx.doi.org/10.1016/s1957-2557(16)30174-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Mokaddem, M., C. Zouaoui, I. Rojbi, N. Makni, A. Jaidane, H. Ouertani, and B. Zidi. "Diabète type 1 et dyslipidémie." Annales d'Endocrinologie 74, no. 4 (September 2013): 404. http://dx.doi.org/10.1016/j.ando.2013.07.583.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Cheikhrouhou, N., I. Barka, H. Yosra, A. Maarroufi, M. Chaieb, and K. Ach. "HTA et diabète type 1." Annales d'Endocrinologie 77, no. 4 (September 2016): 528. http://dx.doi.org/10.1016/j.ando.2016.07.846.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Laurian, Claude. "Chirurgie bariatrique : impact sur la stratégie thérapeutique (obésité – diabète de type 2)." Sang thrombose vaisseaux 24, no. 5 (May 2012): 207–9. http://dx.doi.org/10.1684/stv.2012.0704.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Andreelli, F., and P. Ritz. "Vers de nouvelles recommandations pour la chirurgie du diabète de type 2 ?" Médecine des Maladies Métaboliques 12, no. 2 (March 2018): 168–73. http://dx.doi.org/10.1016/s1957-2557(18)30042-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Plas, C., F. Dalmay, S. Nassouri, A. Drutel, S. Galinat, P. Vital, C. Peyronnet, et al. "Chirurgie bariatrique : quelle technique choisir pour guérir le diabète de type 2 ?" Annales d'Endocrinologie 78, no. 4 (September 2017): 299. http://dx.doi.org/10.1016/j.ando.2017.07.229.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Mouiel, J. "Chirurgie métabolique dans le traitement du diabète de type 2 chez l’obèse." Obésité 8, no. 1 (February 5, 2013): 34–39. http://dx.doi.org/10.1007/s11690-013-0359-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Scheen, André J. "Personnaliser l’approche du diabète de type 2 : chirurgie métabolique et/ou pharmacothérapie." Revue Médicale Suisse 19, no. 838 (2023): 1483–84. http://dx.doi.org/10.53738/revmed.2023.19.838.1483.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

D, Y. M. "Du diabète gestationnel au diabète de type 2." Option/Bio 26, no. 526-527 (May 2015): 8. http://dx.doi.org/10.1016/s0992-5945(15)30164-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

A, F. "Quels mécanismes pour la rémission du diabète après chirurgie bariatrique ?" Médecine des Maladies Métaboliques 10, no. 5 (September 2016): 463. http://dx.doi.org/10.1016/s1957-2557(16)30148-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Vergès, Bruno. "Diabète de type 1 : aspects particuliers." Médecine des Maladies Métaboliques 15, no. 4 (June 2021): 356–57. http://dx.doi.org/10.1016/j.mmm.2021.05.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chabbert-Buffet, Nathalie. "Diabète de type 1 et fertilité." Médecine des Maladies Métaboliques 15, no. 4 (June 2021): 364–68. http://dx.doi.org/10.1016/j.mmm.2021.04.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Hober, D., L. Andréoletti, C. Hober, S. Belaïch, MC Vantyghem, J. Lefèbvre, and P. Wattré. "Entérovirus et diabète de type 1." médecine/sciences 14, no. 4 (1998): 398. http://dx.doi.org/10.4267/10608/1054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Dubois-Laforgue, D., and J. Timsit. "Diabète de type 1 et environnement." médecine/sciences 16, no. 10 (2000): 1045. http://dx.doi.org/10.4267/10608/1523.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

A., F. "Entérovirus et diabète de type 1." Médecine des Maladies Métaboliques 5, no. 1 (February 2011): 83. http://dx.doi.org/10.1016/s1957-2557(11)70195-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Vergès, B. "Lipides et diabète de type 1." Médecine des Maladies Métaboliques 7, no. 5 (October 2013): 437–42. http://dx.doi.org/10.1016/s1957-2557(13)70533-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

A, F. "Lipides et diabète de type 1." Médecine des Maladies Métaboliques 11, no. 1 (February 2017): 78. http://dx.doi.org/10.1016/s1957-2557(17)30017-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Simeoni, Julia. "Étiopathogénie du diabète de type 1." Annales d'Endocrinologie 67, no. 1 (March 2006): 98–99. http://dx.doi.org/10.1016/s0003-4266(06)72558-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Boursier, L., C. Mettavant, and T. Crea. "Cyclophosphamide et diabète de type 1." Annales d'Endocrinologie 78, no. 4 (September 2017): 417. http://dx.doi.org/10.1016/j.ando.2017.07.653.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Setti, M. Amar. "Diabète sucré type 1 post-greffe." Annales d'Endocrinologie 79, no. 4 (September 2018): 479. http://dx.doi.org/10.1016/j.ando.2018.06.937.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

McGibbon, Angela, Cindy Richardson, Cheri Hernandez, and John Dornan. "Pharmacothérapie du diabète de type 1." Canadian Journal of Diabetes 37 (October 2013): S422—S427. http://dx.doi.org/10.1016/j.jcjd.2013.07.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Büsser, Claudio, Patrick Meyer, and François R. Jornayvaz. "Sport et diabète de type 1." Revue Médicale Suisse 9, no. 389 (2013): 1200–1205. http://dx.doi.org/10.53738/revmed.2013.9.389.1200.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

A., F. "Type 1 lent ou diabète de type 2 ?" Médecine des Maladies Métaboliques 9, no. 1 (February 2015): 64. http://dx.doi.org/10.1016/s1957-2557(15)30012-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Camponovo, Chiara, Anne Wojtusciszyn, Patricia Gilet, and Lucie Favre. "Traitement du diabète de type 2 avant, pendant et après la chirurgie métabolique." Revue Médicale Suisse 16, no. 687 (2020): 582–85. http://dx.doi.org/10.53738/revmed.2020.16.687.0582.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Raggenbass-Frischknecht, Axelle, and Giacomo Gastaldi. "Traitement du diabète de type 2 : risques et bénéfices de la chirurgie métabolique." Revue Médicale Suisse 13, no. 565 (2017): 1150–57. http://dx.doi.org/10.53738/revmed.2017.13.565.1150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Besrour, C., I. Rojbi, M. Majdoub, R. Laamouri, N. Mchirgui, Y. Lakhoua, I. Ben Nacef, and K. Khiari. "Diabète de type 1 et diabète insipide : à propos d’une observation." Annales d'Endocrinologie 82, no. 5 (October 2021): 518. http://dx.doi.org/10.1016/j.ando.2021.08.779.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Kherrab, H., S. Behidj, Z. Nehar, N. Kesaci, H. Bouchaib, and B. Oudjit. "Diabète type 1 et la polyendocrinopathie auto-immune type 1." Diabetes & Metabolism 38 (March 2012): A116—A117. http://dx.doi.org/10.1016/s1262-3636(12)71466-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Khiari, M., F. Boukhayatia, H. Zahra, R. Mizouri, S. Zribi, A. Temessek, and F. Ben Mami. "La décompensation cétosique entre le diabète de type 1 et le diabète de type 2." Annales d'Endocrinologie 79, no. 4 (September 2018): 486. http://dx.doi.org/10.1016/j.ando.2018.06.962.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Dalhoum, M., N. Ben Amor, F. Mahjoub Essid, O. Berriche, I. Bani, H. Ben Yamna, I. Lahmar, A. Gamoudi, and H. Jamoussi. "Diabète type 1 et maladies auto-immunes." Annales d'Endocrinologie 82, no. 5 (October 2021): 523. http://dx.doi.org/10.1016/j.ando.2021.08.795.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Dondonne, Alexandre, Nicolas Paquot, Karine Fombellida, and Régis P. Radermecker. "Risque cardiovasculaire et diabète de type 1." Revue Médicale Suisse 17, no. 747 (2021): 1392–96. http://dx.doi.org/10.53738/revmed.2021.17.747.1392.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rouland, Matthieu, Léo Bertrand, and Agnès Lehuen. "Microbiote, immunité et diabète de type 1." Médecine des Maladies Métaboliques 16, no. 2 (March 2022): 134–40. http://dx.doi.org/10.1016/j.mmm.2022.01.005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Baïzri, H., and S. Elhadri. "P226 NASH et diabète de type 1." Diabetes & Metabolism 40 (March 2014): A81. http://dx.doi.org/10.1016/s1262-3636(14)72517-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

A., F. "Diabète de type 1 et fonctions cognitives." Médecine des Maladies Métaboliques 1, no. 2 (June 2007): 72. http://dx.doi.org/10.1016/s1957-2557(07)88637-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Brindisi, M. C., B. Vergès, and S. Halimi. "Complications cardiovasculaires du diabète de type 1." Médecine des Maladies Métaboliques 4, no. 5 (October 2010): 563–72. http://dx.doi.org/10.1016/s1957-2557(10)70123-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

A., F. "Thérapies préventives du diabète de type 1." Médecine des Maladies Métaboliques 5, no. 2 (April 2011): 186–87. http://dx.doi.org/10.1016/s1957-2557(11)70217-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

A., F. "Oméga 3 et diabète de type 1." Médecine des Maladies Métaboliques 5, no. 3 (June 2011): 322. http://dx.doi.org/10.1016/s1957-2557(11)70251-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles